To address the nationwide concern of costly immunotherapy agents, this article features health system inpatient and outpatient strategies that can help mitigate their costs.
Carina Verdier Dolan, PharmD, BCOP
Advertisement
Articles by Carina Verdier Dolan, PharmD, BCOP
Advertisement
Latest Updated Articles
- Evolving Practices in Managing Costly Immunotherapy
February 8th 2016
Advertisement
Advertisement
Trending on AJMC
1
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
2
New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease
3
Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship
4
Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home
5